Public Profile

Watson Laboratories, Inc.

Watson Laboratories, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1984, the company has established itself as a leader in the development and manufacturing of generic and branded medications, primarily focusing on therapeutic areas such as dermatology, women's health, and urology. With a commitment to quality and innovation, Watson Laboratories offers a diverse portfolio of products, including oral and topical formulations that cater to the evolving needs of healthcare providers and patients. The company has achieved significant milestones, including strategic acquisitions that have expanded its market presence and product offerings. Recognised for its dedication to excellence, Watson Laboratories continues to strengthen its position in the competitive pharmaceutical landscape, making strides in both domestic and international markets.

DitchCarbon Score

How does Watson Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

37

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Watson Laboratories, Inc.'s score of 37 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

53%

Let us know if this data was useful to you

Watson Laboratories, Inc.'s reported carbon emissions

Watson Laboratories, Inc., headquartered in the US, currently does not have available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the sector increasingly focuses on sustainability, Watson Laboratories may need to establish clear climate commitments and reduction initiatives to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Watson Laboratories, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Watson Laboratories, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Watson Laboratories, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ferring Pharmaceuticals Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Sandoz International GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers